Our work showed that the AFAP1-AS1 level was elevated in chemotherapy-resistant patients for the first time, which motivated us to look further for a relationship between AFAP1-AS1 and drug resistance in cervical cancer. This evidence concerns the gene AFAP1 and cervical carcinoma.